Skip to content

Sweet Thresholds in Healthy Volunteers Study

Assessing Taste Thresholds and Scores on Standardised Mood Questionnaires in Participants Without Mood Disorders

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06697847
Enrollment
30
Registered
2024-11-20
Start date
2024-11-27
Completion date
2025-03-14
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Taste Thresholds in Healthy Volunteers

Keywords

Taste thresholds, Healthy volunteers

Brief summary

The sweet threshold (concentration of sucrose in water) at which healthy participants can detect a sweet flavour will be recorded.

Detailed description

The sweet threshold (concentration of sucrose in water) at which healthy participants can detect a sweet flavour will be recorded by means of application on a cotton bud to the anterior third of the tongue. Solutions will be presented in a pseudo-randomised order. Mood questionnaires will be completed (to check that participants are indeed healthy). The questionnaires used will be the Patient Health Questionnaire 9 (PHQ9), Beck's Depression Inventory (BDI) and Generalised Anxiety Disorder Questionnaire 7 (GAD-7). This data is being collected with the intention of its use for comparison with sweet thresholds established in other populations using the same method of sweet threshold estimation.

Interventions

None listed

Sponsors

Ranvier Health Ltd
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

. Male and female adults of 18 years old and over; * Participants without a diagnosis of major depressive disorder (MDD) / anxiety disorder; * Participants not taking an antidepressant during the preceding 6 months * Not suffering from significant other mental or physical illness, such as confirmed psychosis, end of life care, or any other condition assessed as significant by the Site Investigator; * Willing and able to comply with all study-related procedures; * Not having COVID 19 or continuing effects of COVID 19 including altered sense of taste; * Understands the study requirements and the treatment procedures and is able to provide written informed consent.

Exclusion criteria

* Taking antidepressant medication currently or during the previous 6 months; * Known or suspected hypersensitivity or intolerance to any taste testing solutions, or any of their excipients; * A history or presence of neurological or confounding psychiatric conditions (such as stroke, traumatic brain injury, epilepsy, space occupying lesions, multiple sclerosis, Parkinson's disease, vascular dementia, transient ischemic attack, or schizophrenia); * Patients with a diagnosis of chronic pain; * Pregnancy or possibility pregnancy, or breastfeeding; * Participants using supplements containing psychoactive herbs (for example St Johns Wort or 5-HTP (5-Hydroxytryptophan, also known as oxitriptan); * Participants regularly using psychoactive stimulants (for example MDMA); * Participants unable or unwilling to comply with study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Sweet taste thresholdFrom enrolment to a final taste test 6 weeks laterSweet taste threshold established by applying varying concentrations of sucrose solution to the tongue and assessing whether a sweet taste can be detected by the participant. The sweet threshold is the minimum concentration at which a participant can reliably detect the sweet flavour.

Secondary

MeasureTime frameDescription
Score on Becks Depression InventoryFrom enrolment to a final questionnaire 6 weeks laterBecks depression inventory will be completed by the participant at the first and last visit. The score will be calculated to check that the participant is free of mood disorder. The scale ranges from 1-40 and a score of less than 10 is normal. Higher scores suggest increasing degrees of depression.
Score on Patient Health Questionnaire 9From enrolment to a final questionnaire 6 weeks laterPatient Health Questionnaire 9 will be completed by the participant at the first and last visit. The score will be calculated to check that the participant is free of mood disorder. The scale ranges from 0-27 and a score less than 5 suggests the subject is not depressed.
Score on Generalised Anxiety Disorder scale 7From enrolment to a final questionnaire 6 weeks laterGeneralised Anxiety Disorder scale 7 will be completed by the participant at the first and last visit. The score will be calculated to check that the participant is free of mood disorder. The scale ranges from 0-21. A score of less than 4 suggests minimal anxiety and increasing scores suggest greater anxiety symptoms.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 23, 2026